Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04008303
Other study ID # 190993
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date May 2020
Est. completion date June 1, 2020

Study information

Verified date January 2021
Source Vanderbilt University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Migraines are very common and affect over 35 million Americans a year. Migraines can be painful and affect daily life. The cause of migraine is multifactorial and not completely understood. Treatment usually includes different classes of medications, life style changes, physical therapy, acupuncture, nerve stimulators and avoiding common triggers (like bright lights, certain foods, or loud sounds). For some patients, Botox injected into the muscles of the forehead and neck can significantly reduce pain. Unfortunately, this does not provide long-term relief as the effect of Botox lasts for 3 months. Since year 2000 surgery to treat a selected population of migraine patients has been gaining popularity and showing promising results. The surgery reduces the pressure on the peripheral nerves that are believed to cause migraine headaches by resecting the surrounding tissue (bone, fascia, muscle, and arteries). This surgery provides a more long-term and permanent relief. The purpose of this study is to follow the effectiveness and outcomes of migraine surgery.


Description:

Migraines are very common and affect over 35 million Americans a year. Migraines can be painful and affect daily life. The cause of migraine is multifactorial and not completely understood. Treatment usually includes different classes of medications, life style changes, physical therapy, acupuncture, nerve stimulators and avoiding common triggers (like bright lights, certain foods, or loud sounds). For some patients, Botox injected into the muscles of the forehead and neck can significantly reduce pain. Unfortunately, this does not provide long-term relief as the effect of Botox lasts for 3 months. Since year 2000 surgery to treat a selected population of migraine patients has been gaining popularity and showing promising results. The surgery reduces the pressure on the peripheral nerves that are believed to cause migraine headaches by resecting the surrounding tissue (bone, fascia, muscle, and arteries). This surgery provides a more long-term and permanent relief. The purpose of this study is to follow the effectiveness and outcomes of migraine surgery.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years or older - Cleared by neurology and headache specialists for surgery - Patient cleared by neurology for not having medication overuse headaches - Patient able to localize a consistent trigger site where the migraines start - Patient has been suffering from migraine for more than 2 years - Botox injections or nerve blocks have worked for migraine relief in the past - Patients formally diagnosed with migraine headaches by a neurologist - Migraines impact quality of life per MIDAS survey - No history of Mania, Bipolar disorder, Major Dispersive disorder, or suicidal ideation Exclusion Criteria: - High dose opioid medication use - Does not meet criteria for migraine diagnosis - History of prior surgery for migraines

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Migraine surgery
Surgical decompression of neuromuscular structures causing migraine headaches.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Vanderbilt University Medical Center

References & Publications (10)

Gfrerer L, Guyuron B. Surgical treatment of migraine headaches. Acta Neurol Belg. 2017 Mar;117(1):27-32. doi: 10.1007/s13760-016-0731-1. Epub 2016 Dec 24. Review. — View Citation

Guyuron B, Kriegler JS, Davis J, Amini SB. Comprehensive surgical treatment of migraine headaches. Plast Reconstr Surg. 2005 Jan;115(1):1-9. — View Citation

Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg. 2011 Feb;127(2):603-8. doi: 10.1097/PRS.0b013e3181fed456. — View Citation

Guyuron B, Reed D, Kriegler JS, Davis J, Pashmini N, Amini S. A placebo-controlled surgical trial of the treatment of migraine headaches. Plast Reconstr Surg. 2009 Aug;124(2):461-8. doi: 10.1097/PRS.0b013e3181adcf6a. — View Citation

Guyuron B, Varghai A, Michelow BJ, Thomas T, Davis J. Corrugator supercilii muscle resection and migraine headaches. Plast Reconstr Surg. 2000 Aug;106(2):429-34; discussion 435-7. — View Citation

Janis JE, Barker JC, Javadi C, Ducic I, Hagan R, Guyuron B. A review of current evidence in the surgical treatment of migraine headaches. Plast Reconstr Surg. 2014 Oct;134(4 Suppl 2):131S-41S. doi: 10.1097/PRS.0000000000000661. — View Citation

Lee M, Monson MA, Liu MT, Reed D, Guyuron B. Positive botulinum toxin type a response is a prognosticator for migraine surgery success. Plast Reconstr Surg. 2013 Apr;131(4):751-7. doi: 10.1097/PRS.0b013e3182818b7f. — View Citation

Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec;6(6):429-40. Epub 2005 Dec 15. Review. — View Citation

Negro A, Rocchietti-March M, Fiorillo M, Martelletti P. Chronic migraine: current concepts and ongoing treatments. Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1401-20. Review. — View Citation

Stewart WF, Simon D, Shechter A, Lipton RB. Population variation in migraine prevalence: a meta-analysis. J Clin Epidemiol. 1995 Feb;48(2):269-80. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Frequency Frequency
Number of migraine headaches per day
Number of migraine headaches per week
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Duration Duration
-How long the migraine headaches last in minutes
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Location Location
Area of head that hurts with migraines.
Options include front, side, top, and back.
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Quality Quality
Description of the migraine pain.
Options include sharp, stabbing, dull, pulsating, and burning.
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Severity Severity
- Migraine headache severity graded on a 0-10 scale, with 10 being the most severe.
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Laterality Laterality
Side of the head that is impacted with migraine headaches
Options include right, left, or both.
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Associated Symptoms Associated symptoms
Question to record associated symptoms that occur with migraine headaches
Options include nausea, vomiting, photophobia, photophobia, and aura symptoms
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Exacerbating factors Exacerbating factors
Open ended question to record anything that makes the migraine headaches worse.
Examples include medications, environmental triggers (light, noise, etc), and lifestyle (stress, exercise, etc)
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
Primary Change in International Classification of Headache Disorders Diagnostic criteria: Relieving factors Relieving factors
Open ended question to record anything that makes the migraine headaches better.
Examples include medications, avoidance of environmental triggers (light, noise, etc), and lifestyle changes (stress avoidance, exercise, etc)
1 month intervals at 1 month, 1 year, 2 years, and 5 years post-operative
See also
  Status Clinical Trial Phase
Completed NCT05525611 - Cabergoline as a Preventive Treatment for Chronic Migraine N/A
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Not yet recruiting NCT06428838 - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Phase 3
Completed NCT06304675 - Manageable Environmental Factors in Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05517200 - Pilot Study for a Machine Learning Test for Migraine
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Active, not recruiting NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A